Antitrust Law Daily Wrap Up, WORTH NOTING—Other Antitrust and Trade Regulation developments, (Jul 7, 2016)
Law Firms Mentioned:Buchanan Ingersoll & Rooney PC | Davis Wright Tremaine LLP | DeBenedictis & DeBenedictis LLC | Hausfeld LLP | Kasowitz, Benson, Torres & Friedman LLP | Lowenstein Sandler PC | Patunas Tarantino LLC | Pepper Hamilton LLP | Weinstein Kitchenoff & Asher LLC
Organizations Mentioned:Buchanan Ingersoll & Rooney, PC | Davis Wright Tremaine, LLP | Hausfeld, LLP | Hillandale Gettysburg LP | International Brotherhood of Electrical Workers | International Brotherhood of Electrical Workers, Local 38, Health and Welfare Fund | International Brotherhood of Electrical Workers, Local 595 Health and Welfare Fund | Kasowitz Benson Torres & Friedman, LLP | Lowenstein Sandler, PC | National Food Corp. | NuCal Foods, Inc. | Pepper Hamilton, LLP | SmithKline Beecham Corp. | Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries, Ltd. | Teva Pharmaceuticals USA, Inc. | United Egg Producers, Inc. | Weinstein Kitchoff & Asher, LLC
A periodic roundup of other items of interest to the Antitrust and Trade Regulation community:
ANTITRUST—E.D. Pa. In multidistrict litigation concerning an alleged conspiracy to fix the price of eggs, direct purchasers have been reimbursed more than $1.3 million for expenses and each individual class representative has been awarded $25,000 as an incentive award. The court concluded that the proposed incentive awards were reasonable because the plaintiffs secured more than $50 million in settlements and the class representatives placed themselves at risk of retaliation by defendants, given their continued purchase of eggs and egg products following the litigation (In re Processed Egg Products Antitrust Litigation, July 5, 2016, Pratter, G.).
ANTITRUST—D.N.J. Pharmaceutical companies SmithKline Beecham Corp. and Teva Pharmaceutical Industries Ltd. have been denied a request to stay proceedings, in a pay-for-delay action concerning the prescription drug Lamictal, pending the Supreme Court’s final ruling on a petition for certiorari in the related case SmithKline Beecham Corp. v. King Drug Co. of Florence (Dkt. 15-1055). Alleged indirect purchasers claimed that the two pharmaceutical companies entered into an agreement to delay generic competition for the medication Lamictal, a prescription drug that is used to treat epilepsy and bipolar disorder (In re Lamictal Indirect Purchaser and Antitrust Consumer Litigation, July 6, 2016, Walls, W.).
Attorneys: Michael John DeBenedictis (DeBenedictis & DeBenedictis LLC) for International Brotherhood of Electrical Workers, Local 38, Health and Welfare Fund and International Brotherhood of Electrical Workers, Local 595 Health and Welfare Fund. Douglas Scott Eakeley (Lowenstein Sandler PC) for SmithKline Beecham Corp. Mayra Velez Tarantino (Patunas Tarantino LLC) for Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. Mindee J. Reuben (Weinstein Kitchenoff & Asher LLC) and Michael D. Hausfeld (Hausfeld LLP) for Direct Purchaser Plaintiffs. Stephen M. Rummage (Davis Wright Tremaine LLP) for National Food Corp. Jan P. Levine (Pepper Hamilton LLP) for United Egg Producers, Inc. William M. Goodman (Kasowitz, Benson, Torres & Friedman LLP) for NuCal Foods, Inc. Samantha L. Southall (Buchanan Ingersoll & Rooney PC) for Hillandale Gettysburg LP.
Companies: International Brotherhood of Electrical Workers, Local 38, Health and Welfare Fund; International Brotherhood of Electrical Workers, Local 595 Health and Welfare Fund; SmithKline Beecham Corp.; Teva Pharmaceutical Industries Ltd.; Teva Pharmaceuticals USA, Inc.; National Food Corp.; United Egg Producers, Inc.; NuCal Foods, Inc.; Hillandale Gettysburg LP
News: Antitrust PennsylvaniaNews NewJerseyNews